The major focus of the CRE REDUCE is to translate new knowledge into health policy and practice.
Given the ongoing treatment failures of infections and the escalation of resistance, timely translation of the findings is required.
Our consumer team members will contribute to this process by providing feedback to the research team through the CRE REDUCE.
The centre has been designed so that all clinical practice guidelines can be translated by 2020. Translation will be facilitated by:
- publishing clinical results and clinical practice guidelines,
- presenting to relevant federal and state bodies and professional societies, and
- ensuring consumer team members can share results with the community.